What are the major opportunities in the Neoantigen Targeted Therapies market? What are the strategies for the Neoantigen Targeted Therapies market?

For detailed insights on the major opportunities and strategies in the Neoantigen Targeted Therapies market, Read More

How does the Neoantigen Targeted Therapies market relate to the overall economy and other similar markets?

For detailed insights on Neoantigen Targeted Therapies's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Neoantigen Targeted Therapies market growth? SWOT analysis of the Neoantigen Targeted Therapies market.

For detailed insights on the key dynamics influencing the Neoantigen Targeted Therapies market growth and SWOT analysis of the Neoantigen Targeted Therapies industry, Read More

Neoantigen Targeted Therapies Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Neoantigen Targeted Therapies Market Report 2026

Name: Neoantigen Targeted Therapies Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Monotherapy, Combination Therapy), By Immunotherapy Type (DNA Or RNA-Based Vaccines, Protein-Based Vaccines, Dendritic Cell Vaccines, TIL-Based Therapies), By Target Disease Indication (Colorectal Cancer, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Bone Cancer, Gynecological Cancer), By Route Of Administration (Intradermal, Intravenous, Subcutaneous), By Application (Medical Research Institution, Hospitals and Clinics, Other Applications) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Neoantigen Targeted Therapies Market Overview

• Neoantigen Targeted Therapies market size has reached to $4.71 billion in 2025

• Expected to grow to $21.52 billion in 2030 at a compound annual growth rate (CAGR) of 35.5%

• Growth Driver: Surge Of Precision Oncology Propels Growth In The Neoantigen Targeted Therapies Market

• Market Trend: Strategic Partnerships In Neoantigen Targeted Therapies To Personalize Cancer Treatment And Enhance Immunotherapy Effectiveness

• North America was the largest region in 2025.

What Is Covered Under Neoantigen Targeted Therapies Market?

Neoantigen-targeted therapies are a type of precision medicine that concentrates on neoantigens in cancer cells. Neoantigens are distinct antigens that are derived from genetic abnormalities or modifications present in cancer cells. It is used to harness the body's immune system to recognize and attack cancer cells specifically by targeting these neoantigens.

The main types of neoantigens targeted therapies are monotherapy and combination therapy. The term monotherapy refers to a medical approach to treating a problem or disease that uses only one medicine or therapy. The various immunotherapy types include DNA or RNA-based vaccines, protein-based vaccines, dendritic cell vaccines, and TIL-based therapies that target various disease indications such as colorectal cancer, renal cell carcinoma, non-small cell lung cancer, bone cancer, and gynecological cancer. The various routes of administration include intradermal, intravenous, and subcutaneous, and the various applications include medical research institutions, hospitals, clinics, and others.

Neoantigen Targeted Therapies Market Global Report 2026 Market Report bar graph

What Is The Neoantigen Targeted Therapies Market Size and Share 2026?

The neoantigen targeted therapies market size has grown exponentially in recent years. It will grow from $4.71 billion in 2025 to $6.39 billion in 2026 at a compound annual growth rate (CAGR) of 35.8%. The growth in the historic period can be attributed to limited immunotherapy options, slow cancer vaccine development, early-stage genomic sequencing usage, restricted clinical trial availability, traditional oncology treatment dependency.

What Is The Neoantigen Targeted Therapies Market Growth Forecast?

The neoantigen targeted therapies market size is expected to see exponential growth in the next few years. It will grow to $21.52 billion in 2030 at a compound annual growth rate (CAGR) of 35.5%. The growth in the forecast period can be attributed to rapid growth of personalized cancer therapies, increased investment in genomic sequencing, expanding clinical research collaborations, rising adoption of combination immunotherapies, growing demand for precision oncology solutions. Major trends in the forecast period include increasing adoption of personalized cancer vaccines, expansion of targeted immunotherapy research pipelines, rising clinical trials for neoantigen-based combination therapies, growing demand for early genetic profiling in oncology, surge in development of til-based therapeutic approaches.

Book your 30 minutes free consultation with our research experts

Global Neoantigen Targeted Therapies Market Segmentation

1) By Type: Monotherapy, Combination Therapy

2) By Immunotherapy Type: DNA Or RNA-Based Vaccines, Protein-Based Vaccines, Dendritic Cell Vaccines, TIL-Based Therapies

3) By Target Disease Indication: Colorectal Cancer, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Bone Cancer, Gynecological Cancer

4) By Route Of Administration: Intradermal, Intravenous, Subcutaneous

5) By Application: Medical Research Institution, Hospitals and Clinics, Other Applications

Subsegments:

1) By Monotherapy: Individual Neoantigen-Targeted Treatments

2) By Combination Therapy: Neoantigen-Targeted Therapies Combined With Other Immunotherapies, Neoantigen-Targeted Therapies Combined With Chemotherapy, Neoantigen-Targeted Therapies Combined With Targeted Therapies

What Is The Driver Of The Neoantigen Targeted Therapies Market?

The rising precision oncology is expected to propel the growth of the neoantigen targeted therapies market going forward. Precision oncology is an approach to cancer treatment that utilizes detailed genetic and molecular information about a patient's tumor to guide the selection of targeted therapies. Precision oncology uses neoantigen-targeted therapies by leveraging advanced genomic analysis to identify unique neoantigens expressed by an individual's cancer cells. The utilization of neoantigen-targeted therapies in precision oncology reflects a strategy to address the specific genetic makeup of each patient's tumor, offering a more personalized and effective treatment option. For instance, in March 2024, according to the Precision Oncology Clinical Trials & Statistics 2024 report published by Novotech, an Australia-based full-service clinical contract research organization involved in the development of innovative therapeutics across all phases, by November 2023, twelve treatments had received FDA approval for specific biomarker-selected indications, with six of these also included in the NCCN guidelines. By the year's end, 43% of the 217 FDA-approved oncology therapies were classified as precision oncology, and 78 of these therapies featured DNA or NGS-detectable biomarkers, highlighting the growing prominence of biomarker-driven treatments in cancer care. Therefore, rising precision oncology is driving the growth of the neoantigen-targeted therapies market.

Key Players In The Global Neoantigen Targeted Therapies Market

Major companies operating in the neoantigen targeted therapies market are F. Hoffmann-La Roche AG, Merck and Co. Inc., Bristol Myers Squibb Company, Kite Pharma Inc., Amgen Inc., Moderna Inc., BioNTech SE, Bavarian Nordic Inc., Advaxis Inc., Immatics NV, Iovance Biotherapeutics Inc., Agenus Inc., Achilles Therapeutics Plc, Medigene AG, Gritstone Bio Inc., SQZ Biotechnologies Company, Aduro BioTech Inc., Inovio Pharmaceuticals Inc., Gradalis Inc., EpiVax Inc., ISA Pharmaceuticals BV, Vaxon Biotech SA, Ziopharm Oncology, Genocea Biosciences Inc., Cellular Biomedicine Group Inc., Immunovaccine Inc.

Global Neoantigen Targeted Therapies Market Trends and Insights

Major companies operating in the neoantigen targeted therapies market are adopting a strategic partnership approach to personalize neoantigen vaccines and monoclonal antibody drugs to overcome the challenges of existing immunotherapy in the treatment of solid tumors. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in April 2023, Moderna, Inc., a US-based pharmaceutical and biotechnology company collaborated with Merck & Co., Inc. a US-based pharmaceutical company that launched mRNA-4157 (V940). It is an investigational individualized neoantigen therapy (INT) designed to generate a tailored antitumor immune response based on the unique mutational signature of a patient's tumor. mRNA-4157 (V940) works by encoding up to 34 neoantigens to stimulate T cell responses, enhancing the body’s ability to target and destroy tumor cells when combined with Merck’s immunotherapy KEYTRUDA. This combination aims to improve recurrence-free survival in patients with high-risk resected melanoma.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Neoantigen Targeted Therapies Market?

In January 2023, AstraZeneca plc, a UK-based pharmaceutical industry company acquired Neogene Therapeutics Inc. for $200 million. This acquisition aims to bolster AstraZeneca’s oncology portfolio, focusing on the development of transformative T-cell receptor (TCR) therapies targeting neoantigens in solid tumors. Neogene's expertise in next-generation TCR-T therapies is expected to complement AstraZeneca's existing capabilities in the oncology space, enabling the company to further its advancements in cancer treatments. Neogene Therapeutics Inc. is a US-based biotechnology company that provides neoantigen-targeted therapies.

Regional Outlook

North America was the largest region in the neoantigen targeted therapies market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Neoantigen Targeted Therapies Market?

The neoantigen targeted therapies market consists of revenues earned by entities by providing services such as the identification and characterization of neoantigens in individual patients, the selection and administration of the appropriate therapy, and the monitoring of patients' responses. The market value includes the value of related goods sold by the service provider or included within the service offering. Neoantigen targeted therapies also include the sale of neoantigen-based cancer vaccines and genetically modified T cells. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Neoantigen Targeted Therapies Market Report 2026?

The neoantigen targeted therapies market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the neoantigen targeted therapies industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Neoantigen Targeted Therapies Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$6.39 billion
Revenue Forecast In 2035	$21.52 billion
Growth Rate	CAGR of 35.8% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Immunotherapy Type, Target Disease Indication, Route Of Administration, Application
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	F. Hoffmann-La Roche AG, Merck and Co. Inc., Bristol Myers Squibb Company, Kite Pharma Inc., Amgen Inc., Moderna Inc., BioNTech SE, Bavarian Nordic Inc., Advaxis Inc., Immatics NV, Iovance Biotherapeutics Inc., Agenus Inc., Achilles Therapeutics Plc, Medigene AG, Gritstone Bio Inc., SQZ Biotechnologies Company, Aduro BioTech Inc., Inovio Pharmaceuticals Inc., Gradalis Inc., EpiVax Inc., ISA Pharmaceuticals BV, Vaxon Biotech SA, Ziopharm Oncology, Genocea Biosciences Inc., Cellular Biomedicine Group Inc., Immunovaccine Inc.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Neoantigen Targeted Therapies Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Neoantigen Targeted Therapies Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Neoantigen Targeted Therapies Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Neoantigen Targeted Therapies Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Immersive Technologies (Ar/Vr/Xr) & Digital Experiences

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Personalized Cancer Vaccines

4.2.2 Expansion Of Targeted Immunotherapy Research Pipelines

4.2.3 Rising Clinical Trials For Neoantigen-Based Combination Therapies

4.2.4 Growing Demand For Early Genetic Profiling In Oncology

4.2.5 Surge In Development Of Til-Based Therapeutic Approaches

5. Neoantigen Targeted Therapies Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Medical Research Institutions

5.4 Oncology Centers

5.5 Cancer Treatment Facilities

6. Neoantigen Targeted Therapies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Neoantigen Targeted Therapies Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Neoantigen Targeted Therapies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Neoantigen Targeted Therapies Market Size, Comparisons And Growth Rate Analysis

7.3. Global Neoantigen Targeted Therapies Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Neoantigen Targeted Therapies Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Neoantigen Targeted Therapies Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Neoantigen Targeted Therapies Market Segmentation

9.1. Global Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Monotherapy, Combination Therapy

9.2. Global Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

DNA Or RNA-Based Vaccines, Protein-Based Vaccines, Dendritic Cell Vaccines, TIL-Based Therapies

9.3. Global Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Colorectal Cancer, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Bone Cancer, Gynecological Cancer

9.4. Global Neoantigen Targeted Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Intradermal, Intravenous, Subcutaneous

9.5. Global Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Medical Research Institution, Hospitals and Clinics, Other Applications

9.6. Global Neoantigen Targeted Therapies Market, Sub-Segmentation Of Monotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Individual Neoantigen-Targeted Treatments

9.7. Global Neoantigen Targeted Therapies Market, Sub-Segmentation Of Combination Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Neoantigen-Targeted Therapies Combined With Other Immunotherapies, Neoantigen-Targeted Therapies Combined With Chemotherapy, Neoantigen-Targeted Therapies Combined With Targeted Therapies

10. Neoantigen Targeted Therapies Market Regional And Country Analysis

10.1. Global Neoantigen Targeted Therapies Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Neoantigen Targeted Therapies Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Neoantigen Targeted Therapies Market

11.1. Asia-Pacific Neoantigen Targeted Therapies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Neoantigen Targeted Therapies Market, Segmentation By Type, Segmentation By Immunotherapy Type, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Neoantigen Targeted Therapies Market

12.1. China Neoantigen Targeted Therapies Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Neoantigen Targeted Therapies Market, Segmentation By Type, Segmentation By Immunotherapy Type, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Neoantigen Targeted Therapies Market

13.1. India Neoantigen Targeted Therapies Market, Segmentation By Type, Segmentation By Immunotherapy Type, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Neoantigen Targeted Therapies Market

14.1. Japan Neoantigen Targeted Therapies Market Overview

14.2. Japan Neoantigen Targeted Therapies Market, Segmentation By Type, Segmentation By Immunotherapy Type, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Neoantigen Targeted Therapies Market

15.1. Australia Neoantigen Targeted Therapies Market, Segmentation By Type, Segmentation By Immunotherapy Type, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Neoantigen Targeted Therapies Market

16.1. Indonesia Neoantigen Targeted Therapies Market, Segmentation By Type, Segmentation By Immunotherapy Type, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Neoantigen Targeted Therapies Market

17.1. South Korea Neoantigen Targeted Therapies Market Overview

17.2. South Korea Neoantigen Targeted Therapies Market, Segmentation By Type, Segmentation By Immunotherapy Type, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Neoantigen Targeted Therapies Market

18.1. Taiwan Neoantigen Targeted Therapies Market Overview

18.2. Taiwan Neoantigen Targeted Therapies Market, Segmentation By Type, Segmentation By Immunotherapy Type, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Neoantigen Targeted Therapies Market

19.1. South East Asia Neoantigen Targeted Therapies Market Overview

19.2. South East Asia Neoantigen Targeted Therapies Market, Segmentation By Type, Segmentation By Immunotherapy Type, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Neoantigen Targeted Therapies Market

20.1. Western Europe Neoantigen Targeted Therapies Market Overview

20.2. Western Europe Neoantigen Targeted Therapies Market, Segmentation By Type, Segmentation By Immunotherapy Type, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Neoantigen Targeted Therapies Market

21.1. UK Neoantigen Targeted Therapies Market, Segmentation By Type, Segmentation By Immunotherapy Type, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Neoantigen Targeted Therapies Market

22.1. Germany Neoantigen Targeted Therapies Market, Segmentation By Type, Segmentation By Immunotherapy Type, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Neoantigen Targeted Therapies Market

23.1. France Neoantigen Targeted Therapies Market, Segmentation By Type, Segmentation By Immunotherapy Type, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Neoantigen Targeted Therapies Market

24.1. Italy Neoantigen Targeted Therapies Market, Segmentation By Type, Segmentation By Immunotherapy Type, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Neoantigen Targeted Therapies Market

25.1. Spain Neoantigen Targeted Therapies Market, Segmentation By Type, Segmentation By Immunotherapy Type, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Neoantigen Targeted Therapies Market

26.1. Eastern Europe Neoantigen Targeted Therapies Market Overview

26.2. Eastern Europe Neoantigen Targeted Therapies Market, Segmentation By Type, Segmentation By Immunotherapy Type, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Neoantigen Targeted Therapies Market

27.1. Russia Neoantigen Targeted Therapies Market, Segmentation By Type, Segmentation By Immunotherapy Type, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Neoantigen Targeted Therapies Market

28.1. North America Neoantigen Targeted Therapies Market Overview

28.2. North America Neoantigen Targeted Therapies Market, Segmentation By Type, Segmentation By Immunotherapy Type, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Neoantigen Targeted Therapies Market

29.1. USA Neoantigen Targeted Therapies Market Overview

29.2. USA Neoantigen Targeted Therapies Market, Segmentation By Type, Segmentation By Immunotherapy Type, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Neoantigen Targeted Therapies Market

30.1. Canada Neoantigen Targeted Therapies Market Overview

30.2. Canada Neoantigen Targeted Therapies Market, Segmentation By Type, Segmentation By Immunotherapy Type, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Neoantigen Targeted Therapies Market

31.1. South America Neoantigen Targeted Therapies Market Overview

31.2. South America Neoantigen Targeted Therapies Market, Segmentation By Type, Segmentation By Immunotherapy Type, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Neoantigen Targeted Therapies Market

32.1. Brazil Neoantigen Targeted Therapies Market, Segmentation By Type, Segmentation By Immunotherapy Type, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Neoantigen Targeted Therapies Market

33.1. Middle East Neoantigen Targeted Therapies Market Overview

33.2. Middle East Neoantigen Targeted Therapies Market, Segmentation By Type, Segmentation By Immunotherapy Type, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Neoantigen Targeted Therapies Market

34.1. Africa Neoantigen Targeted Therapies Market Overview

34.2. Africa Neoantigen Targeted Therapies Market, Segmentation By Type, Segmentation By Immunotherapy Type, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Neoantigen Targeted Therapies Market Regulatory and Investment Landscape

36. Neoantigen Targeted Therapies Market Competitive Landscape And Company Profiles

36.1. Neoantigen Targeted Therapies Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Neoantigen Targeted Therapies Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Neoantigen Targeted Therapies Market Company Profiles

36.3.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Kite Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Neoantigen Targeted Therapies Market Other Major And Innovative Companies

Moderna Inc., BioNTech SE, Bavarian Nordic Inc., Advaxis Inc., Immatics NV, Iovance Biotherapeutics Inc., Agenus Inc., Achilles Therapeutics Plc, Medigene AG, Gritstone Bio Inc., SQZ Biotechnologies Company, Aduro BioTech Inc., Inovio Pharmaceuticals Inc., Gradalis Inc., EpiVax Inc.

38. Global Neoantigen Targeted Therapies Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Neoantigen Targeted Therapies Market

40. Neoantigen Targeted Therapies Market High Potential Countries, Segments and Strategies

40.1 Neoantigen Targeted Therapies Market In 2030 - Countries Offering Most New Opportunities

40.2 Neoantigen Targeted Therapies Market In 2030 - Segments Offering Most New Opportunities

40.3 Neoantigen Targeted Therapies Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Neoantigen Targeted Therapies Market, Overview Of Key Products - Product Examples

Table 2: Global Neoantigen Targeted Therapies Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Neoantigen Targeted Therapies Market, Supply Chain Analysis

Table 4: Global Neoantigen Targeted Therapies Market, Major Raw Material Providers

Table 5: Global Neoantigen Targeted Therapies Market, Major Resource Providers

Table 6: Global Neoantigen Targeted Therapies Market, Major Manufacturers (Suppliers)

Table 7: Global Neoantigen Targeted Therapies Market, Major Distributors And Channel Partners

Table 8: Global Neoantigen Targeted Therapies Market, Key Technologies & Future Trends

Table 9: Global Neoantigen Targeted Therapies Market, Major Trends

Table 10: Global Neoantigen Targeted Therapies Market, Major End Users

Table 11: Global Neoantigen Targeted Therapies Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Neoantigen Targeted Therapies Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Neoantigen Targeted Therapies Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Neoantigen Targeted Therapies Market - TAM, US$ Billion, 2025

Table 15: Global Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Neoantigen Targeted Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Neoantigen Targeted Therapies Market, Sub-Segmentation Of Monotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Neoantigen Targeted Therapies Market, Sub-Segmentation Of Combination Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Neoantigen Targeted Therapies Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Neoantigen Targeted Therapies Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Neoantigen Targeted Therapies Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Neoantigen Targeted Therapies Market - Company Scoring Matrix

Table 98: F. Hoffmann-La Roche AG Financial Performance

Table 99: Merck and Co. Inc. Financial Performance

Table 100: Bristol Myers Squibb Company Financial Performance

Table 101: Kite Pharma Inc. Financial Performance

Table 102: Amgen Inc. Financial Performance

Table 103: Global Neoantigen Targeted Therapies Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Neoantigen Targeted Therapies Market, Competitive Dashboard

Table 105: Global Neoantigen Targeted Therapies Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Neoantigen Targeted Therapies Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 107: Global, Neoantigen Targeted Therapies Market Size Gain ($ Billion), Segmentation By Immunotherapy Type, 2025 – 2030

Table 108: Global, Neoantigen Targeted Therapies Market Size Gain ($ Billion), Segmentation By Target Disease Indication, 2025 – 2030

List Of Figures

Figure 1: Global Neoantigen Targeted Therapies Market, Overview Of Key Products - Product Examples

Figure 2: Global Neoantigen Targeted Therapies Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Neoantigen Targeted Therapies Market, Supply Chain Analysis

Figure 4: Global Neoantigen Targeted Therapies Market, Major Raw Material Providers

Figure 5: Global Neoantigen Targeted Therapies Market, Major Resource Providers

Figure 6: Global Neoantigen Targeted Therapies Market, Major Manufacturers (Suppliers)

Figure 7: Global Neoantigen Targeted Therapies Market, Major Distributors And Channel Partners

Figure 8: Global Neoantigen Targeted Therapies Market, Key Technologies & Future Trends

Figure 9: Global Neoantigen Targeted Therapies Market, Major Trends

Figure 10: Global Neoantigen Targeted Therapies Market, Major End Users

Figure 11: Global Neoantigen Targeted Therapies Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Neoantigen Targeted Therapies Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Neoantigen Targeted Therapies Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Neoantigen Targeted Therapies Market - TAM, US$ Billion, 2025

Figure 15: Global Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Neoantigen Targeted Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Neoantigen Targeted Therapies Market, Sub-Segmentation Of Monotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Neoantigen Targeted Therapies Market, Sub-Segmentation Of Combination Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Neoantigen Targeted Therapies Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Neoantigen Targeted Therapies Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Neoantigen Targeted Therapies Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Neoantigen Targeted Therapies Market - Company Scoring Matrix

Figure 98: F. Hoffmann-La Roche AG Financial Performance

Figure 99: Merck and Co. Inc. Financial Performance

Figure 100: Bristol Myers Squibb Company Financial Performance

Figure 101: Kite Pharma Inc. Financial Performance

Figure 102: Amgen Inc. Financial Performance

Figure 103: Global Neoantigen Targeted Therapies Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Neoantigen Targeted Therapies Market, Competitive Dashboard

Figure 105: Global Neoantigen Targeted Therapies Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Neoantigen Targeted Therapies Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 107: Global, Neoantigen Targeted Therapies Market Size Gain ($ Billion), Segmentation By Immunotherapy Type, 2025 – 2030

Figure 108: Global, Neoantigen Targeted Therapies Market Size Gain ($ Billion), Segmentation By Target Disease Indication, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

RNA Targeting Small Molecules Therapeutics Market Report 2026 - Global Outlook – By Offering (mRNA (Messenger Ribonucleic Acid) Translation Modulators, RNA (Ribonucleic Acid) Splicing Modification, Direct RNA (Ribonuclei...

Intratumoral Cancer Therapies Market Report 2026 - Global Outlook – By Technology (Monoclonal Antibodies, Vaccines, Checkpoint Inhibitors, Cell Therapies, Immunes System Modulator, Adoptive Cell Transfer, Cytokines ), By...

Gene Therapy Market Report 2026 - Global Outlook – By Gene Therapy Type (Germline Therapy, Somatic Cell Therapy), By Vector (Viral Vector, Non-Viral Vector), By Application (Oncology, Orphan Disease, Knee Osteoarthritis,...

Neoantigen Targeted Therapies Market Report 2026 - Global Outlook – By Type (Monotherapy, Combination Therapy), By Immunotherapy Type (DNA Or RNA-Based Vaccines, Protein-Based Vaccines, Dendritic Cell Vaccines, TIL-Based...

Targeted Therapy Market Report 2026 - Global Outlook – By Type (Small Molecule Medicines, Monoclonal Antibodies), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies ), By Application (Brea...

Anti-Neoplastic Agents Market Report 2026 - Global Outlook – By Type (Alkylating Agents, Antimetabolites, Hormones And Antagonists, Miscellaneous), By Disease Type (Gastrointestinal Cancer, Prostate Cancer, Lung Cancer, ...

Leukemia Therapeutics Market Report 2026 - Global Outlook – By Treatment Type (Chemotherapy, Immunotherapy, Targeted Therapy, Other Treatments), By Type Of Leukemia (Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Ch...

Frequently Asked Questions

How big is the Neoantigen Targeted Therapies Market?

The Neoantigen Targeted Therapies market was valued at $4.71 billion in 2025, increased to $6.39 billion in 2026, and is projected to reach $21.52 billion by 2030. request a sample here

What is the Neoantigen Targeted Therapies market growth?

The global Neoantigen Targeted Therapies market is expected to grow at a CAGR of 35.5% from 2026 to 2035 to reach $21.52 billion by 2035. request a sample here

Who are the key players in Neoantigen Targeted Therapies market?

Some Key Players in the Neoantigen Targeted Therapies market Include, F. Hoffmann-La Roche AG, Merck and Co. Inc., Bristol Myers Squibb Company, Kite Pharma Inc., Amgen Inc., Moderna Inc., BioNTech SE, Bavarian Nordic Inc., Advaxis Inc., Immatics NV, Iovance Biotherapeutics Inc., Agenus Inc., Achilles Therapeutics Plc, Medigene AG, Gritstone Bio Inc., SQZ Biotechnologies Company, Aduro BioTech Inc., Inovio Pharmaceuticals Inc., Gradalis Inc., EpiVax Inc., ISA Pharmaceuticals BV, Vaxon Biotech SA, Ziopharm Oncology, Genocea Biosciences Inc., Cellular Biomedicine Group Inc., Immunovaccine Inc. . request a sample here

What is the anticipated growth trend for the Neoantigen Targeted Therapies market?

Major trend in this market includes: Strategic Partnerships In Neoantigen Targeted Therapies To Personalize Cancer Treatment And Enhance Immunotherapy Effectiveness. For further insights on this market. request a sample here

Which region has the most growth potential in the Neoantigen Targeted Therapies market?

North America was the largest region in the neoantigen targeted therapies market in 2025. The regions covered in the neoantigen targeted therapies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Who are the key players in the Neoantigen Targeted Therapies Market Report 2026 market?

Major companies operating in the Neoantigen Targeted Therapies Market Report 2026 market are Major companies operating in the neoantigen targeted therapies market are F. Hoffmann-La Roche AG, Merck and Co. Inc., Bristol Myers Squibb Company, Kite Pharma Inc., Amgen Inc., Moderna Inc., BioNTech SE, Bavarian Nordic Inc., Advaxis Inc., Immatics NV, Iovance Biotherapeutics Inc., Agenus Inc., Achilles Therapeutics Plc, Medigene AG, Gritstone Bio Inc., SQZ Biotechnologies Company, Aduro BioTech Inc., Inovio Pharmaceuticals Inc., Gradalis Inc., EpiVax Inc., ISA Pharmaceuticals BV, Vaxon Biotech SA, Ziopharm Oncology, Genocea Biosciences Inc., Cellular Biomedicine Group Inc., Immunovaccine Inc. request a sample here.

Which region has the most growth potential in the Neoantigen Targeted Therapies Market Report 2026 market?